Foreword – No-reflow: Basic science to a clinical phenomenon R. A. Kloner FOCUSED ISSUE-No-reflow 18 August 2006 Pages: 357 - 358
The no-reflow phenomenon: A basic mechanism of myocardial ischemia and reperfusion T. ReffelmannR. A. Kloner FOCUSED ISSUE-No-reflow 18 August 2006 Pages: 359 - 372
Coronary microembolization A. SkyschallyK. LeineweberG. Heusch FOCUSED ISSUE-No-reflow 18 August 2006 Pages: 373 - 382
Assessment of no-reflow regions using cardiac MRI T. S. E. AlbertR. J. KimR. M. Judd FOCUSED ISSUE-No-reflow 18 August 2006 Pages: 383 - 390
Evaluating the ‘no reflow’ phenomenon with myocardial contrast echocardiography S. Kaul FOCUSED ISSUE-No-reflow 18 August 2006 Pages: 391 - 399
Combination study of myocardial perfusion and left ventricular filling provides an excellent prediction of clinical outcomes in patients with reperfused myocardial infarction H. ItoN. KomuraK. Fujii FOCUSED ISSUE-No-reflow 18 August 2006 Pages: 400 - 407
Activation of ERK and suppression of calcineurin are interacting mechanisms of cardioprotection afforded by δ-opioid receptor activation Yoshihiro IkedaTetsuji MiuraKazuaki Shimamoto ORIGINAL CONTRIBUTION 17 April 2006 Pages: 418 - 426
Myocardial injury modulates the innate immune system and changes myocardial sensitivity Georg BaumgartenSe-Chan KimPascal Knuefermann ORIGINAL CONTRIBUTION 12 May 2006 Pages: 427 - 435
β1-Adrenergic receptor antagonism abrogates cardioprotective effects of intermittent hypoxia Robert T. MalletMyoung-Gwi RyouH. Fred Downey ORIGINAL CONTRIBUTION 16 May 2006 Pages: 436 - 446
Better identification of patients who benefit from implantable cardioverter defibrillators by genotyping the G protein β3 subunit (GNB3) C825T polymorphism Heinrich WienekeChristoph N. NaberWinfried Siffert ORIGINAL CONTRIBUTION 16 June 2006 Pages: 447 - 451